Semi-Annual Statement Of Income And Retained Earnings

Immuno-Biological Laboratories Co., Ltd. - Filing #7325711

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
107,816,000 JPY
104,299,000 JPY
-3,516,000 JPY
104,299,000 JPY
JPY
112,642,000 JPY
57,148,000 JPY
70,493,000 JPY
70,493,000 JPY
JPY
-13,344,000 JPY
57,148,000 JPY
Non-operating income
Non-operating income
22,337,000 JPY
34,092,000 JPY
18,477,000 JPY
20,423,000 JPY
Non-operating expenses
Non-operating expenses
1,223,000 JPY
920,000 JPY
22,997,000 JPY
227,075,000 JPY
Ordinary profit (loss)
125,413,000 JPY
145,815,000 JPY
65,973,000 JPY
-149,503,000 JPY
Extraordinary income
Extraordinary income
JPY
JPY
12,000 JPY
45,799,000 JPY
Extraordinary losses
Extraordinary losses
769,000 JPY
21,590,000 JPY
688,147,000 JPY
176,908,000 JPY
Profit (loss) before income taxes
124,644,000 JPY
124,225,000 JPY
-622,162,000 JPY
-280,611,000 JPY
Income taxes - current
5,857,000 JPY
5,438,000 JPY
8,806,000 JPY
9,119,000 JPY
Income taxes - deferred
-67,908,000 JPY
-67,908,000 JPY
JPY
JPY
Profit (loss)
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-289,731,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.